brometo de rocurônio Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

brometo de rocurônio

instituto biochimico indÚstria farmacÊutica ltda - brometo de rocurÔnio - bloqueador neuromuscular

Phelinun Ευρωπαϊκή Ένωση - Πορτογαλικά - EMA (European Medicines Agency)

phelinun

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - agentes antineoplásicos - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

UNIREZ Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

unirez

uniÃo quÍmica farmacÊutica nacional s/a - brometo de rocurÔnio - bloqueador neuromuscular

ESTRIONIL Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

estrionil

hipolabor farmaceutica ltda - estriol - hormonios sexuais exclusive ocitocicos